9th International mRNA Health Conference
November 2021
Berlin
online
Nov 8: Arrival & Get together in the evening
Nov 9/10: Conference Days
Thank you very much for your participation at the 9th International mRNA Health Conference!
The recordings of the sessions are now available on the online platform until February 15, 2022. After this date, the platform will be taken offline, so please safe all necessary information.
*You have already received your access data in a separate e-mail after completing your booking
Please click here
9th International mRNA Health Conference
The International mRNA Health Conference (Conference Days November 9 and 10, 2021) is the premier meeting destination for industry and academic professionals to explore the rapidly advancing science and business of mRNA medicines.
2020 and 2021 have been especially interesting years for mRNA technology. The end of last year marked a breakthrough for the technology with the approval of the first mRNA-based medicine. Together, with outstanding scientists and future-oriented companies, we would like to recognize the successes and potential of mRNA technology.
The mRNA Health Conference provides participants with a platform for networking with experts, giving them an opportunity to learn more about developments in mRNA technology and to see scientific presentations by some of the most esteemed experts in the field.
The event brings together over 650 attendees from leading pharma and biotech companies as well as academic institutions. Due to the ongoing COVID-19 pandemic, the conference is currently planned as a hybrid event on-site in Berlin and via a virtual platform. If a physical event is not possible due to safety concerns related to COVID-19, the event will take place exclusively online.
The registration tool as well as the sponsorship application for the 9th International mRNA Health Conference are now available.
If you would like to stay updated on the details of the event, please sign up for our newsletter.
We look forward to your participation.